An analysis of the size, scope and the role of the Netherlands (RAND)
Bibliography: Economics
Changes in Europe’s cannabis resin market
This analysis describes how the supply of cannabis resin in Europe is changing in response to competition and other market developments (EMCDDA)
ACT Trends in Ecstasy and Related Drug Markets 2015
Findings from the Ecstasy and Related Drugs Reporting System (EDRS)
EMCDDA Budget 2016
The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre’s Director to the Management Board, which may modify the draft before adopting it and submitting it to the European Commission. The Commission, in turn, makes its recommendations (which may again alter the draft) and presents the result to the European Council and Parliament
Drug Money: the illicit proceeds of opiates trafficked on the Balkan route
This study focuses on a vital aspect of illicit drug trafficking: the huge profits that flow from this trade into the hands of criminals and their networks. South-Eastern Europe, through the so-called Balkan route, is a key pathway for the delivery of opiates from Afghanistan into Western and Central Europe (UNODC)
Potential fiscal impacts of introducing a regulated cannabis market in the UK
This note considers the potential net savings and the potential tax revenue associated with introducing a regulated cannabis market, drawing on the examples of Colorado, Washington State and Uruguay (TDPF)
Alcohol’s cost to society Vs taxpayer: politics and the £21 billion
The debate over the cost of alcohol to society – not to be confused with the cost to the taxpayer – has been reignited by a report from the Institute of Economic Affairs (IEA) and critical response from the Institute of Alcohol Studies (Alcohol Policy UK)
Profit from drugs inside prisons feeding crime outside, police leaders warned
Police forces have been told to face up to the “fall-out” from Britain’s burgeoning prison population as the Government sets out a bold new-for-old building programme (Police Professional)
AOD treatment spending in Australia
Alcohol and other drug treatment spending in Australia amounted to $1.2 billion in 2012/2013 (NDARC)
Blanket ban to clamp down on ‘legal highs’
Action to protect young people from the dangers of so-called ‘legal highs’ and target those who profit from their trade was announced by the UK government (Home Office)
Tackling Harmful Alcohol Use
Economics and Public Health Policy (OECD)
Historic Requests for Treatment and Prevention in President Obama’s 2016 Budget
In response to America’s drug problem, the 2016 Budget reflects the Administration’s ongoing commitment to reducing drug use and its consequences through a balanced approach rooted in science. Budget highlights (ONDCP)
Understanding the Costs and Savings to Public Services of Different Treatment Pathways for Clients Dependent on Opiates
This paper presents a summary of analysis that considered the costs and savings to public services that might be generated from those receiving treatment for opiate dependence (Department for Work and Pensions, UK)
HIV sweeps across eastern Europe amid economic crisis
HIV is spreading at a dangerous rate in nations around the Black Sea, passing a record 100,000 new cases yearly (EU Observer)
The Rise and Challenge of Dark Net Drug Markets
This policy brief examines the expansion of drug markets on the Dark Net or ‘hidden web’ and the challenges they pose for both law enforcement agencies and the international legal framework within which those agencies ultimately operate (GDPO)
How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia
The drug market period in which injecting initiation occurred influenced the first drug injected and influenced some aspects of subsequent drug use. In the context of highly dynamic drug markets in which polydrug use is common there is a need for broad harm reduction and drug treatment services which are flexible and responsive to changing patterns of drug use (Drug Policy)
